Form 8.3 - WILLIS TOWERS WATSON PLC

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 20 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

 

 

 

 

1,708,247

1.32%

165,008

0.13%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

7,100

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,786,706

1.39%

178,208

0.14%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

1

238.0300 USD

Purchase

10

238.6000 USD

Purchase

15

238.5400 USD

Purchase

34

237.9475 USD

Purchase

45

238.5500 USD

Purchase

69

238.0000 USD

Purchase

89

238.1007 USD

Purchase

96

238.2000 USD

Purchase

100

237.7000 USD

Purchase

100

238.5900 USD

Purchase

100

238.0400 USD

Purchase

107

236.5523 USD

Purchase

400

238.0500 USD

Purchase

550

237.5909 USD

Purchase

682

238.1680 USD

Purchase

800

237.4287 USD

Purchase

800

238.0812 USD

Purchase

1,105

237.5796 USD

Purchase

1,108

238.1110 USD

Purchase

1,356

238.3521 USD

Purchase

1,862

238.0516 USD

Purchase

2,734

237.9299 USD

Purchase

4,300

238.5530 USD

Purchase

4,436

237.9873 USD

Purchase

5,233

238.0582 USD

Purchase

5,323

238.6133 USD

Purchase

5,735

238.5771 USD

Purchase

6,092

238.0360 USD

Purchase

6,445

237.2308 USD

Purchase

7,173

238.0269 USD

Purchase

11,402

237.2300 USD

Purchase

13,406

237.9586 USD

Purchase

31,274

237.6459 USD

Sale

1

237.4300 USD

Sale

15

237.9150 USD

Sale

20

238.5500 USD

Sale

34

237.9475 USD

Sale

50

238.5470 USD

Sale

92

236.4451 USD

Sale

101

237.9703 USD

Sale

116

237.7541 USD

Sale

200

238.0400 USD

Sale

299

237.8367 USD

Sale

336

237.9634 USD

Sale

700

238.0957 USD

Sale

833

238.1205 USD

Sale

989

237.5592 USD

Sale

1,633

237.9969 USD

Sale

2,435

238.0049 USD

Sale

5,868

237.9672 USD

Sale

6,445

237.2308 USD

Sale

6,773

238.0275 USD

Sale

7,847

238.0461 USD

Sale

10,219

237.9415 USD

Sale

10,508

238.3340 USD

Sale

11,504

237.2300 USD

Sale

35,964

237.6871 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 21 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 735661
Time of Receipt (offset from UTC): 20210421T121143+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC